Posted 3/26/2010 12:11 AM (GMT 0)
The FDA has approved Boehringer Ingelheim Pharmaceuticals’ Mirapex ER (pramipexole dihydrochloride) once-daily, extended-release tablets for the signs and symptoms of idiopathic Parkinson disease (PD), including early and advanced PD. Studies showed that patients with advanced PD who were treated with Mirapex ER experienced superior symptom relief versus placebo. Mirapex ER also demonstrated benefits similar to those of Mirapex (pramipexole dihydrochloride) tablets, each versus placebo, while significantly reducing off-time (period of time when symptoms return) versus placebo.
Just thought it was some good info.